Publications
- Incidence of adverse events after loading phase of the brolucizumab therapy of neovascular AMD: Real-life evidence in the Czech Republic2023 | Faculty of Medicine in Hradec Králové, Central Library of Charles University, First Faculty of Medicine, Third Faculty of Medicine
- Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes2023 | Faculty of Medicine in Hradec Králové, Central Library of Charles University, Third Faculty of Medicine
- Diabetic Macular Edema - Diagnostics and Treatment Guidelines2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- Retina2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration: A Phase 3 Randomized Clinical Trial2023 | Central Library of Charles University, Third Faculty of Medicine
- Diabetic Retinopathy - Diagnostics and Treatment Guidelines2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Diabetic Retinopathy and Diabetic Macular Edema - Screening2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Biosimilar SB15 versus reference aflibercept in neovascular age-related macular degeneration: 1-year and switching results of a phase 3 clinical trial2023 | Central Library of Charles University, Third Faculty of Medicine
- Rheoferéza v léčbě věkem podmíněné makulární degenerace2023 | Faculty of Medicine in Hradec Králové
- Rheohemapheresis in the Treatment of Dry Form of AMD. A Case Report2023 | Faculty of Medicine in Hradec Králové
Loading network view...